E
SRRA

Ergoteles’s Sierra Oncology, Inc. Common Stock SRRA Stock Holding History

Ergoteles’s Portfolio SRRA Stock Details SRRA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-125,354
Closed -$6.89M – 2247
2022
Q2 		$6.89M Buy
+125,354
New +$6.58M 0.21% 126

Other funds holding SRRA

HI
Harbour Investments Madison, Wisconsin $6.48B AUM 18.23% 1-Year Est. Return

Ergoteles's SRRA Position: Q3 2022 in Review

Ergoteles sold out of Sierra Oncology, Inc. Common Stock (SRRA) in Q3 2022, closing a stake of 125,354 shares — an estimated $6.89M sold.

Ergoteles first reported a position in SRRA in Q2 2022 and held it in 1 quarter. The position peaked at $6.89M in Q2 2022. 1 fund tracked by Wall St. Rank holds SRRA as of Q3 2022.

  • Ergoteles reported no remaining Sierra Oncology, Inc. Common Stock position as of Q3 2022 after selling out during the quarter.
  • Ergoteles sold 125,354 Sierra Oncology, Inc. Common Stock shares in Q3 2022, an estimated $6.89M.
  • Ergoteles first reported a position in Sierra Oncology, Inc. Common Stock in Q2 2022 and held it in 1 quarter.
  • Ergoteles's Sierra Oncology, Inc. Common Stock position peaked at $6.89M in Q2 2022.
  • 1 fund tracked by Wall St. Rank held Sierra Oncology, Inc. Common Stock as of Q3 2022.

Based on Ergoteles's 13F filing for Q3 2022, filed 14 Nov 2022.